GENinCode (LON:GENI) Issues Earnings Results

GENinCode (LON:GENI) issued its quarterly earnings data on Tuesday. The company reported GBX (0.38) EPS for the quarter, Digital Look Earnings reports. GENinCode had a negative return on equity of 481.34% and a negative net margin of 202.42%.

GENinCode Price Performance

GENinCode stock opened at GBX 0.65 on Thursday. GENinCode has a 52 week low of GBX 0.64 and a 52 week high of GBX 4.90. The company’s 50 day moving average price is GBX 0.88 and its two-hundred day moving average price is GBX 0.98. The stock has a market cap of £4.89 million, a P/E ratio of -0.31 and a beta of 0.59. The company has a quick ratio of 15.88, a current ratio of 2.22 and a debt-to-equity ratio of 4.75.

GENinCode Company Profile

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.